Can an invasive coronary angiogram miss clinically significant coronary artery blockages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Invasive Coronary Angiography Miss Coronary Blockages?

Yes, invasive coronary angiography can miss clinically significant coronary artery disease, particularly functional stenoses, microvascular dysfunction, and endothelial dysfunction—which is why current guidelines mandate complementary coronary pressure assessment (FFR/iFR) be readily available during angiography to avoid missing hemodynamically significant lesions 1.

Why Angiography Alone Is Insufficient

Invasive coronary angiography provides only anatomical visualization of epicardial coronary arteries. The 2024 ESC guidelines explicitly state there is a "frequent mismatch between the angiographic and haemodynamic severities of coronary stenoses" 1. This means:

  • Visual assessment underestimates or overestimates lesion severity: A stenosis may appear non-obstructive (<50%) on angiography but still cause flow limitation
  • Interobserver variability is substantial: Recent data shows 22.6% disagreement among experienced cardiologists reading the same angiograms 2
  • Functional significance cannot be determined visually: Case reports document "near-normal" angiograms with vessel-specific ischemia confirmed by FFR 3

What Gets Missed Without Functional Assessment

1. Hemodynamically Significant Stenoses That Look Mild

In patients with angina and "non-obstructive" CAD (<50% stenosis), comprehensive invasive evaluation reveals 4:

  • 44% have endothelial dysfunction (>20% vasoconstriction with acetylcholine)
  • 21% have microvascular impairment (index of microcirculatory resistance ≥25)
  • 5% have functionally significant stenoses (FFR ≤0.80)
  • Only 23% have truly normal coronaries with no explanation for angina

2. Microvascular Dysfunction (MVA)

The 2024 ESC guidelines emphasize that in ANOCA/INOCA (angina with non-obstructive coronary arteries), 41% have microvascular angina and 40% have vasospastic angina 1. Standard angiography cannot detect these conditions—you need:

  • Coronary flow reserve (CFR) measurement
  • Index of microcirculatory resistance (IMR)
  • Acetylcholine provocation testing for vasospasm

3. Diffuse Atherosclerosis

Intravascular ultrasound (IVUS) studies show all patients with angina have at least some atherosclerosis even when angiography appears normal 4. Diffuse disease without focal stenoses escapes visual detection.

Clinical Algorithm: When to Suspect Missed Disease

Proceed with functional assessment if:

  1. Persistent angina despite "normal" angiogram (no stenosis >50%)

    • Measure FFR/iFR on any intermediate lesions (40-69% stenosis)
    • Assess CFR and IMR for microvascular dysfunction
    • Consider acetylcholine provocation for vasospasm
  2. Discordance between symptoms and angiographic findings

    • Patient has typical angina at low exercise levels
    • Stress testing showed moderate-severe ischemia pre-catheterization
    • Left ventricular dysfunction suggesting ischemic cardiomyopathy
  3. Intermediate stenoses (40-69% diameter stenosis)

    • The 2023 ACC/AHA guidelines define these as requiring physiological assessment 5
    • FFR/iFR values are continuous variables—don't rely on dichotomous cutpoints alone

Critical Pitfalls to Avoid

Common mistake: Assuming a "negative" angiogram (stenosis <50%) means no coronary disease and stopping the workup. This occurs in 49.5% of chronic coronary syndrome angiograms 6, yet many have occult pathology.

Correct approach: The 2024 ESC guidelines state that in suspected ANOCA/INOCA with no significant epicardial CAD, "additional investigation" for microvascular and vasospastic disorders is indicated 1. Don't discharge these patients as "non-cardiac chest pain" without functional testing.

Extensive calcification: Can cause both visual underestimation on angiography AND computational errors in CT-derived FFR 7. When heavy calcification is present, invasive FFR is more reliable than FFRCT.

Real-World Implications

Recent registry data shows increasing prevalence of non-obstructive disease (32.4% to 41.4% over a decade) 6, yet these patients have:

  • Increased morbidity and mortality 1
  • Impaired quality of life 1
  • Recurrent hospitalizations 4
  • Persistent symptoms despite "normal" angiograms 8

The bottom line: Angiography without physiological assessment misses functionally significant disease in a substantial minority of patients. The 2024 ESC guidelines mandate that "coronary pressure assessment should be readily available to complement ICA investigation for clinical decision-making" 1. This is not optional—it's standard of care for avoiding missed diagnoses that impact mortality and quality of life.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.